• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19.

作者信息

Vargas-Accarino Elena, Martínez-Campreciós Joan, Domínguez-Hernández Raquel, Rando-Segura Ariadna, Riveiro-Barciela Mar, Rodríguez-Frías Francisco, Barreira Ana, Palom Adriana, Casado Miguel Ángel, Esteban Rafael, Buti María

机构信息

Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

J Viral Hepat. 2022 Jul;29(7):579-583. doi: 10.1111/jvh.13686. Epub 2022 May 23.

DOI:10.1111/jvh.13686
PMID:35555847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9321878/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d21/9347937/c499d18b7b63/JVH-29-579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d21/9347937/c499d18b7b63/JVH-29-579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d21/9347937/c499d18b7b63/JVH-29-579-g001.jpg

相似文献

1
Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19.对积极寻找失访丙型肝炎病毒（HCV）患者（RELINK-C策略）的成本效益分析以及2019年冠状病毒病（COVID-19）的影响。
J Viral Hepat. 2022 Jul;29(7):579-583. doi: 10.1111/jvh.13686. Epub 2022 May 23.
2
Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil.巴西新冠疫情期间丙型肝炎连续护理的远程监测
Telemed J E Health. 2023 Nov;29(11):1673-1678. doi: 10.1089/tmj.2022.0306. Epub 2023 Mar 9.
3
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.针对减少伤害和注射吸毒者慢性丙型肝炎治疗流程的干预措施的有效性和成本效益：以法国为例。
J Viral Hepat. 2018 Oct;25(10):1197-1207. doi: 10.1111/jvh.12919. Epub 2018 May 9.
4
Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.在可负担得起的直接抗病毒药物时代，希腊丙型肝炎消除策略的经济评估。
World J Gastroenterol. 2019 Mar 21;25(11):1327-1340. doi: 10.3748/wjg.v25.i11.1327.
5
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.系统评价：直接作用抗病毒药物时代丙型肝炎病毒筛查的经济评价。
Aliment Pharmacol Ther. 2019 May;49(9):1126-1133. doi: 10.1111/apt.15201. Epub 2019 Mar 6.
6
Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons.美国监狱内丙型肝炎病毒检测、治疗和与护理衔接的成本效益和预算影响
Clin Infect Dis. 2020 Mar 17;70(7):1388-1396. doi: 10.1093/cid/ciz383.
7
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.在瑞士监禁环境中对扩大丙型肝炎病毒筛查及使用直接抗病毒药物治疗的影响和成本效益进行建模
Clin Infect Dis. 2019 Nov 13;69(11):1980-1986. doi: 10.1093/cid/ciz088.
8
Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan.估算直接作用抗病毒药物治疗丙型肝炎在日本的成本节约价格。
Sci Rep. 2020 Mar 5;10(1):4089. doi: 10.1038/s41598-020-60986-4.
9
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.提高丙型肝炎病毒检测和治疗（HepCATT）接受度的干预措施的成本效益：初级保健中的集群随机对照试验。
BMJ. 2020 Feb 26;368:m322. doi: 10.1136/bmj.m322.
10
Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.不同随访方案检测职业性丙型肝炎病毒感染的成本及成本效益
Gut. 2009 Jan;58(1):105-10. doi: 10.1136/gut.2007.145516. Epub 2008 Sep 29.

引用本文的文献

1
Micro-elimination initiative for hepatitis C screening: insight into gender gaps and undiagnosed individuals.丙型肝炎筛查的微量消除倡议：洞察性别差距和未确诊个体。
Sci Rep. 2025 Mar 18;15(1):9289. doi: 10.1038/s41598-025-91696-4.
2
Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment.一项回顾性病例发现和重新参与活动的结果，旨在提高以前诊断为丙型肝炎病毒的人的直接抗病毒治疗的接受率。
BMC Public Health. 2024 Sep 6;24(1):2427. doi: 10.1186/s12889-024-19919-3.
3
ReLink strategy in diagnosed-but-untreated hepatitis C-positive patients in Germany: report from a single center.

本文引用的文献

1
Impact of the COVID-19 pandemic on HCV elimination in Spain.新冠疫情对西班牙丙型肝炎病毒消除工作的影响。
J Hepatol. 2021 May;74(5):1246-1248. doi: 10.1016/j.jhep.2020.12.018. Epub 2020 Dec 20.
2
Impact of COVID-19 on global HCV elimination efforts.新冠疫情对全球丙型肝炎病毒消除工作的影响。
J Hepatol. 2021 Jan;74(1):31-36. doi: 10.1016/j.jhep.2020.07.042. Epub 2020 Aug 7.
3
Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.
德国诊断但未经治疗的丙型肝炎阳性患者的 ReLink 策略：来自单个中心的报告。
Z Gastroenterol. 2024 Oct;62(10):1701-1707. doi: 10.1055/a-2349-2767. Epub 2024 Jul 16.
4
Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment.慢性丙型肝炎病毒感染：筛查与治疗中持续存在的挑战。
Life (Basel). 2023 Sep 26;13(10):1964. doi: 10.3390/life13101964.
5
Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study.作为丙型肝炎微消除策略的失访 HCV 患者检索：巴西多中心研究的结果。
BMC Infect Dis. 2023 Jul 13;23(1):468. doi: 10.1186/s12879-023-08169-0.
荷兰丙型肝炎消除（CELINE）：全国性检索慢性丙型肝炎失访患者的研究方案。
BMJ Open Gastroenterol. 2020 Apr 12;7(1):e000396. doi: 10.1136/bmjgast-2020-000396. eCollection 2020.
4
Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project.对失访的慢性乙型肝炎和丙型肝炎患者的重新评估：北荷兰肝炎找回项目的结果
Hepatol Med Policy. 2018 Jan 31;3:5. doi: 10.1186/s41124-018-0032-9. eCollection 2018.
5
REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.慢性丙型肝炎的检索和治疗（REACH）：乌得勒支省的微消除结果。
Liver Int. 2019 Mar;39(3):455-462. doi: 10.1111/liv.13959. Epub 2018 Oct 16.
6
Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain.西班牙在可使用直接抗病毒药物前后两种慢性丙型肝炎治疗策略的成本效益分析
Gastroenterol Hepatol. 2017 Aug-Sep;40(7):433-446. doi: 10.1016/j.gastrohep.2017.05.004. Epub 2017 Jun 21.